David Robertson to Anti-Mullerian Hormone
This is a "connection" page, showing publications David Robertson has written about Anti-Mullerian Hormone.
Connection Strength
1.314
-
Robertson DM, Lee CH, Baerwald A. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age. Endocrinol Diabetes Metab. 2021 04; 4(2):e00172.
Score: 0.645
-
Robertson DM, Kumar A, Kalra B, Shah S, Pruysers E, Vanden Brink H, Chizen D, Visser JA, Themmen AP, Baerwald A. Detection of serum antim?llerian hormone in women approaching menopause using sensitive antim?llerian hormone enzyme-linked immunosorbent assays. Menopause. 2014 Dec; 21(12):1277-86.
Score: 0.435
-
Li HWR, Robertson DM, Burns C, Ledger WL. Challenges in Measuring AMH in the Clinical Setting. Front Endocrinol (Lausanne). 2021; 12:691432.
Score: 0.170
-
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 04; 98(4):567-577.
Score: 0.047
-
Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007 Aug; 92(8):3060-7.
Score: 0.016